We are monitoring the impact of COVID-19 on Europe Superdisintegrants Market Get in touch with us for detailed analysis Know More
Share on

Europe Superdisintegrants Market Research Report – Segmented By Product Type, Application, Therapeutic Area & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2747
Pages: 140

Europe Superdisintegrants Market Size (2022 to 2027)

The size of the Europe Superdisintegrants Market is predicted to worth USD 126.10 million by 2027 and USD 89.07 million in 2022, growing at a CAGR of 7.20% during the forecast period.

Growth in the generic market, development of new superdisintegrants for the pharmaceutical sector, rising geriatric population with swollen tablets, rising demand for superdisintegrants products, increasing R&D activities, and rising acceptance of advanced technologies are some of the factors driving the European Superdisintegrants market growth. Chronic disease prevalence is increasing at an exponential rate throughout the region. The rising frequency of these diseases is due to factors such as the spread of viruses, germs, and parasites and the increased adoption of a sedentary lifestyle, hereditary circumstances, and bad dietary habits. The market for superdisintegrants is being driven by the rising use of orally disintegrating tablets, the growing generics market, and novel superdisintegrants for the pharmaceutical sector. Increased use of orally disintegrating tablets and increased healthcare spending and awareness are the key drivers driving market development. Superdisintegrants are utilized in various applications and therapeutic areas, including infectious illnesses, cardiovascular diseases, hematological diseases, neurological diseases, gastrointestinal diseases, inflammatory diseases, and cancer.

Major opportunities for the European superdisintegrants market include developing the pharmaceutical market in this region, increased research into natural superdisintegrants, an increase in the geriatric population, which increases demand for superdisintegrants products, and increased investment in R&D activities. The move-in pharmaceutical production and the general expansion of the pharmaceutical market in these markets provide considerable market growth opportunities. A growing percentage of juvenile patients and the elderly population are unable to take solid medications. These compounds are employed in drug-loaded films as a viscosity-improving agent, improving performance and maintaining high drug content uniformity. Ispaghulla, gellan gum, fenugreek seed mucilage, and gum karaya, among others, offer several benefits over synthetic superdisintegrants, including biodegradability, chemical inertness, and non-toxicity. It may be changed in various ways to create custom materials for medication delivery systems that aim to improve safety by forming an accessible dosing system. Natural superdisintegrants have several advantages over synthetic superdisintegrants, including non-toxicity, chemical inert nature, lower cost, and widespread availability. Furthermore, due to its biodegradable property, considerable research has been conducted to create innovative natural disintegrating agents, which will increase the demand for natural superdisintegrants in the coming years.

During the forecast period, safety and quality issues and the high cost of manufacturing superdisintegrants are likely to limit the growth of the European superdisintegrants market to some extent. Maintaining safety and satisfying the quality requirements of regulators, end-users, medication makers, and, most crucially, patients and achieving immediate efficiency and maximum transparency in supply chain operations are all challenges that market manufacturers face.

This research report on the Europe Superdisintegrants Market has been segmented and sub-segmented into the following categories:

By Product Type:

  • Natural Superdisintegrants
  • Synthetic Superdisintegrants
    • Modified Starch
    • Crospovidone
    • Modified Cellulose
    • Ion Exchange Resins
    • Calcium Silicates
  • Others

By Application: 

  • Capsules
  • Tablets

By Therapeutic Area: 

  • Gastrointestinal diseases
  • Neurological diseases
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological diseases
  • Inflammatory Diseases

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the U.K. is leading the market while Germany is in second place. Increasing financial support for the development of innovative oral dosage forms and constant effort devoted towards providing superior quality and compliant products in the market are the primary factors responsible for the dominance of the U.K and Germany in the market. On the other hand, Germany is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure, and awareness.

The European market for superdisintegrants had a substantial share in the global market in 2020. The European region's supremacy can be ascribed to several pharmaceutical upstarts with huge manufacturing capacity, resulting in high excipient consumption. The region's market growth is projected to be aided by a rising emphasis on better pharmaceutical goods and generics. Because of large pharmaceutical industry companies in Germany, the market for superdisintegrants is expected to develop significantly throughout the projected period. In addition, improved innovation and advanced techniques in the production of superdisintegrants will boost market demand.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the Europe Superdisintegrants Market Profiled in the Report are Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co., and Huber Corporation.

1.Introduction               

                1.1 Market Definition 

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods       

                1.4 General Study Assumptions 

2. Research Methodology                        

                2.1 Introduction            

                2.2 Research Phases   

                                2.2.1 Secondary Research

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design      

                2.4 Study Timeline       

3. Overview                    

                3.1 Executive Summary 

                3.2 Key Inferences      

                3.3 Epidemology           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                             

                4.1 Market Drivers       

                4.2 Market Restraints 

                4.3 Key Challenges      

                4.4 Current Opportunities in the Market           

5. Market Segmentation                           

                5.1 Product Type          

                                5.1.1 Introduction 

                                5.1.2 Natural Superdisintegrants    

                                5.1.3 Synthetic Superdisintegrants

         5.1.3.1 Modified Starch                                

         5.1.3.2 Crospovidone                                    

         5.1.3.3 Modified Cellulose    

         5.1.3.4 Ion Exchange Resins 

         5.1.3.5 Calcium Silicates                                

                                5.1.4 Others      

                                5.1.5  Y-o-Y Growth Analysis, By Product Type   

                                5.1.6  Market Attractiveness Analysis, By Product Type

                                5.1.7  Market Share Analysis, By Product Type   

                5.2 Application

                                5.2.1 Introduction 

                                5.2.2 Capsules  

                                5.2.3 Tablets      

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application       

                                5.2.6 Market Share Analysis, By Application        

                5.3 Therapeutic Area  

                                5.3.1 Introduction 

                                5.3.2 Gastrointestinal diseases  

                                5.3.3 Neurological diseases         

                                5.3.4 Oncology 

                                5.3.5 Infectious Diseases   

                                5.3.6 Cardiovascular Diseases    

                                5.3.7 Haematological diseases   

                                5.3.8 Inflammatory Diseases      

                                5.3.9 Y-o-Y Growth Analysis, By Therapeutic Area  

                                5.3.10  Market Attractiveness Analysis, By Therapeutic Area       

                                5.3.11  Market Share Analysis, By Therapeutic Area         

6. Geographical Analysis                           

                6.1 Introduction            

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

         6.1.3.1 By Geographical Area                                     

         6.1.3.2 By Product Type                                

         6.1.3.3 By Application                                    

         6.1.3.4 By Therapeutic Area 

                                6.1.4  Market Attractiveness Analysis     

         6.1.4.1 By Geographical Area                                     

         6.1.4.2 By Product Type                                

         6.1.4.3 By Application                                    

         6.1.4.4 By Therapeutic Area 

                                6.1.5  Market Share Analysis      

         6.1.5.1 By Geographical Area                                     

         6.1.5.2 By Product Type                                

         6.1.5.3 By Application                                    

         6.1.5.4 By Therapeutic Area 

                6.2 U.K

                6.3 Spain          

                6.4 Germany  

                6.5 Italy            

                6.6 France       

7.Strategic Analysis                     

                7.1 PESTLE analysis      

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis           

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services    

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                      

                8.1 Ashland     

                                8.1.1 Overview 

                                8.1.2 Product Type Analysis        

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View

                8.2 BASF SE     

                8.3 FMC Corporation  

                8.4 JRS Pharma

                8.5 DFE Pharma 

                8.6 Roquette  

                8.7 The Dow Chemical Company           

                8.8 Asahi Kasei Corporation     

                8.9 Nippon Soda Co.   

                8.10 Huber Corporation 

9.Competitive Landscape                         

                9.1 Market share analysis         

                9.2 Merger and Acquisition Analysis    

                9.3 Agreements, collaborations and Joint Ventures      

                9.4 New Product Launches      

10.Market Outlook and Investment Opportunities                       

Appendix                        

                a) List of Tables                                     

  1. Europe Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  2. Europe Natural Superdisintegrants Market, By Region, From 2022 - 2027 (USD Billion)
  3. Europe Synthetic Superdisintegrants Market, By Region, From 2022 - 2027 (USD Billion)
  4. Europe Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  5. Europe Capsules Market, By Region, From 2022 - 2027 (USD Billion)
  6. Europe Tablets Market, By Region, From 2022 - 2027 (USD Billion)
  7. Europe Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  8. Europe Gastrointestinal Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  9. Europe Neurological Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  10. Europe Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  11. Europe Infectious Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  12. Europe Cardiovascular Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  13. Europe Haematological Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  14. Europe Inflammatory Diseases Market, By Region, From 2022 - 2027 (USD Billion)
  15. U.K. Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  16. U.K. Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  17. U.K. Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  18. Germany Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  19. Germany Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  20. Germany Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  21. France Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  22. France Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  23. France Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  24. Italy Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  25. Italy Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  26. Italy Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  27. Spain Superdisintegrants Market, By Product Type, From 2022 - 2027 (USD Billion)
  28. Spain Superdisintegrants Market, By Application, From 2022 - 2027 (USD Billion)
  29. Spain Superdisintegrants Market, By Therapeutic Area, From 2022 - 2027 (USD Billion)
  30. Europe Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  31. Europe Modified Starch Market, By Region, From 2022 - 2027 (USD Billion)
  32. Europe Crospovidone Market, By Region, From 2022 - 2027 (USD Billion)
  33. Europe Modified Cellulose Market, By Region, From 2022 - 2027 (USD Billion)
  34. Europe Ion Exchange Resins Market, By Region, From 2022 - 2027 (USD Billion)
  35. Europe Calcium Silicates Market, By Region, From 2022 - 2027 (USD Billion)
  36. U.K. Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  37. Germany Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  38. France Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  39. Italy Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  40. Spain Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  41. Europe Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  42. Europe Modified Starch Market, By Region, From 2022 - 2027 (USD Billion)
  43. Europe Crospovidone Market, By Region, From 2022 - 2027 (USD Billion)
  44. Europe Modified Cellulose Market, By Region, From 2022 - 2027 (USD Billion)
  45. Europe Ion Exchange Resins Market, By Region, From 2022 - 2027 (USD Billion)
  46. Europe Calcium Silicates Market, By Region, From 2022 - 2027 (USD Billion)
  47. U.K. Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  48. Germany Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  49. France Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  50. Italy Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)
  51. Spain Superdisintegrants Market, By Synthetic Superdisintegrants, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample